Morningside Center for Innovative and Affordable Medicine

Molecules

The Morningside Center for Innovative and Affordable Medicine (Morningside Center) is an interdisciplinary unit within the Woodruff Health Sciences Center at Emory University consisting of a core group of staff, and affiliated faculty from across Emory. Extending the vision of GlobalCures Inc., a non-profit medical research organization, the Morningside Center was created to promote research, education, and advocacy for effective and affordable medical treatments. The Morningside Center is supported by the generosity of the Woodruff Fund, Inc. and The Morningside Foundation.

In the current biomedical discovery ecosystem, innovation is often driven by potential profitability. Ideas that could rapidly result in inexpensive, new, life-saving treatments often remain unexplored and are not brought to the market because of lack of financial incentives. This situation leaves many untapped opportunities. The Morningside Center seeks to fill this gap by primarily focusing on repurposing FDA approved drugs. Nutraceuticals and lifestyle changes are other areas of interest.

The Morningside Center’s first area of focus is in cancer, a disease for which new drugs are often very expensive. Over time, the Morningside Center will explore therapies in other areas as well as devices and diagnostics.

The Morningside Center will seek strategic alliances with government agencies, foundations, industry, health insurers, health care providers, advocacy groups, and other academic institutions.

In October 2019, the Center for Affordable Medical Innovation was renamed “Morningside Center for Innovative and Affordable Medicine” in recognition of a transformative gift from The Morningside Foundation.